MLB Daily Fantasy Helper: Tuesday 5/2/17
The beauty of daily fantasy baseball is that the top targets are different each and every day. Whether it's the right-handed catcher who destroys left-handed pitching or the mid-range hurler facing a depleted lineup, you're not going to find yourself using the same assets time after time.
While this breaks up the monotony, it can make it hard to decide which players are primed to succeed on a given day. We can help bridge that gap.
In addition to our custom optimal lineups, you can check out our batting and pitching heat maps, which show the pieces in the best spot to succeed on that slate. Put on the finishing touches with our games and lineups page to see who's hitting where and what the weather looks like, and you'll have yourself a snazzy looking team to put up some big point totals. We've also got our Solo Shot Podcast, which breaks down the MLB daily fantasy slate each day. Here's today's episode.
If you need help getting started on that trek, here are some of the top options on the board today.
Pitchers to Target
Chris Sale ($11,700 on FanDuel): If it's possible for one of the most expensive assets in the sport to be underpriced, then that's the billing Chris Sale deserves. Sure, $11,700 is spendy, but how often can you find a guy with a 2.05 SIERA and 37.4% strikeout rate? The answer -- outside of Sale -- is never for 2017 as he leads the league in both categories. He also boasts the second-highest swinging-strike rate at 17.0% while walking just 4.3% of opposing hitters. The Baltimore Orioles make plenty of loud contact against lefties, but they also have the second-highest strikeout rate in the league at 26.2%. Even with a steady breeze blowing out to center, Sale is easily the top arm you can get.
To read all premium content, upgrade to a Premium account with numberFire
If you're not a Premium subscriber, it takes just a few seconds to sign up. You'll get access to all of our insider information, game projections, handicapping advice, DFS tools, advanced statistics, and more.